CAMPAIGNS: Healthcare PR - AstraZeneca drug release for migraine

Client: AstraZeneca
PR Team: CPR Worldwide
Campaign: European launch of Zomig Nasal Spray
Timescale: August - October 2002
Budget: Undisclosed

It is estimated that one in ten people suffer from migraine, creating a potentially huge market for pharma firms making migraine treatments.

AstraZeneca was not the first company to bring the latest migraine treatments (known as triptans) to market, but has led the way in developing an effective product - Zomig - in a variety of different formulations. Already available in classic tablets and Rapimelt fast-dissolving orange-flavour tablets, in October AstraZeneca asked its retained international agency, CPR Worldwide, to launch the nasal spray version of Zomig in Europe, focusing primarily on the UK and Austria.

Objectives

To ensure maximum awareness of the new formulation of the prescription-only drug among neurologists, GPs and patients.

In a crowded market, the PR team was also keen to highlight the key message that Zomig Nasal Spray delivers fast-acting relief.

Strategy and Plan

The launch campaign centred on grabbing the attention of the world's leading migraine experts, and the media, at Europe's leading neurology congress, the European Federation of Neurological Sciences (EFNS), in Vienna.

From 26 to 30 October, congress delegates were met by a 30ft tall inflatable nasal spray in Zomig brand colours, and invited to visit the AstraZeneca-sponsored Migraine-Free World, an interactive exhibition. Here, participants could get information on triptans while trying out massage chairs and gaining tips on avoiding migraine trigger foods.

On 29 October, an international media briefing was held in the Migraine-Free World and extended to journalists across Europe, via a webcast hosted on AstraZeneca's migrainemediacentre.com website. This highlighted the latest data on migraines and Zomig nasal spray, presented by a panel of migraine experts.

Measurement and Evaluation

The BBC Online and Reuters Health websites covered the story in detail and the Daily Mail made a front page mention and devoted a full page article to the nasal spray.

There was also significant interest from the Austrian national media and UK medical press, including Pharmafocus and Doctor magazine.

Results

An independent onsite survey by Time Research reported that AstraZeneca was one of the companies achieving the highest impact at EFNS.

Almost 90 per cent of delegates visited the Migraine-Free World and 77 per cent of those rated it highly.

It is too early to measure the success of the launch in terms of sales.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.